1. Home
  2. CABA
  3. CABA News

Latest Cabaletta Bio Inc. (CABA) News on September 3, 2025

CABA

MT Newswires

3 months ago

Top Midday Decliners

CABA

MT Newswires

3 months ago

Cabaletta Bio Prices Securities Offering; Shares Fall

Cabaletta Bio Announces Pricing of Public Offering of Securities
CABA

GlobeNewswire

3 months ago

Cabaletta Bio Announces Pricing of Public Offering of Securities

CABA

MT Newswires

3 months ago

Sector Update: Health Care Stocks Higher Pre-Bell Wednesday

CABA

MT Newswires

3 months ago

Top Premarket Decliners

Cabaletta Bio Announces Proposed Public Offering of Securities
CABA

GlobeNewswire

3 months ago

Cabaletta Bio Announces Proposed Public Offering of Securities

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
CABA

GlobeNewswire

3 months ago

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
CABA

GlobeNewswire

3 months ago

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

Biotech Alert: Searches spiking for these stocks today
CABA

TipRanks

3 months ago

Biotech Alert: Searches spiking for these stocks today

CABA

MT Newswires

4 months ago

UBS Adjusts Price Target on Cabaletta Bio to $6 From $7, Maintains Buy Rating

Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
CABA

Simply Wall St.

4 months ago

Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks

CABA

MT Newswires

4 months ago

Cabaletta Bio Extends Gains Premarket as FDA Meeting Fuels Expectations for Myositis BLA Submission

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
CABA

GlobeNewswire

4 months ago

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz
CABA

TipRanks

5 months ago

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz

CABA

MT Newswires

5 months ago

UBS Adjusts Price Target on Cabaletta Bio to $7 From $10, Keeps Buy Rating

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
CABA

GlobeNewswire

5 months ago

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
CABA

Business Wire

5 months ago

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
CABA

GlobeNewswire

6 months ago

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
CABA

GlobeNewswire

7 months ago

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
CABA

GlobeNewswire

7 months ago

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
CABA

GlobeNewswire

7 months ago

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
CABA

GlobeNewswire

7 months ago

Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference

Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
CABA

GlobeNewswire

8 months ago

Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025

CABA

MT Newswires

8 months ago

BofA Securities Cuts Price Target on Cabaletta Bio to $29 From $31, Keeps Neutral Rating

CABA

MT Newswires

8 months ago

Evercore ISI Downgrades Cabaletta Bio to In Line From Outperform, Cuts Price Target to $6 From $15

CABA

MT Newswires

8 months ago

Wells Fargo Downgrades Cabaletta Bio to Equalweight From Overweight, Cuts Price Target to $6 From $12

Cabaletta Bio, Inc.'s (NASDAQ:CABA) latest 25% decline adds to one-year losses, institutional investors may consider drastic measures
CABA

Simply Wall St.

9 months ago

Cabaletta Bio, Inc.'s (NASDAQ:CABA) latest 25% decline adds to one-year losses, institutional investors may consider drastic measures

CABA

MT Newswires

9 months ago

Top Premarket Gainers

CABA

MT Newswires

9 months ago

Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Cabaletta Bio to Advance, Super Micro Computer to Decline

Cabaletta Bio to Participate in Upcoming Investor Conferences in December
CABA

GlobeNewswire

9 months ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
CABA

GlobeNewswire

10 months ago

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
CABA

GlobeNewswire

10 months ago

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
CABA

GlobeNewswire

10 months ago

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate
CABA

Simply Wall St.

10 months ago

We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate

State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings
CABA

GuruFocus.com

a year ago

State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings

CABA

MT Newswires

a year ago

UBS Initiates Cabaletta Bio at Buy With $10 Price Target

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
CABA

GlobeNewswire

a year ago

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

Cabaletta Bio to Participate in Upcoming Investor Conferences in September
CABA

GlobeNewswire

a year ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

CABA

MT Newswires

a year ago

Evercore ISI Cuts Price Target on Cabaletta Bio to $15 From $25, Keeps Outperform Rating

Several Headwinds Dragged Cabaletta Bio (CABA) in Q2
CABA

Insider Monkey

a year ago

Several Headwinds Dragged Cabaletta Bio (CABA) in Q2

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
CABA

GlobeNewswire

a year ago

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio, Inc. (CABA): Why Are Analysts Loving This Shorted Stock Right Now?
CABA

Insider Monkey

a year ago

Cabaletta Bio, Inc. (CABA): Why Are Analysts Loving This Shorted Stock Right Now?

Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
CABA

GlobeNewswire

a year ago

Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum

CABA

MT Newswires

a year ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday

CABA

MT Newswires

a year ago

Sector Update: Health Care

CABA

MT Newswires

a year ago

Cabaletta Bio Says Autoimmune Disease Therapy Showed Promise in Early Results

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
CABA

GlobeNewswire

a year ago

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
CABA

GlobeNewswire

a year ago

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth
CABA

Simply Wall St.

a year ago

We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
CABA

GlobeNewswire

a year ago

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
CABA

GlobeNewswire

a year ago

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway
CABA

GuruFocus.com

a year ago

Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
CABA

GlobeNewswire

a year ago

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
CABA

GlobeNewswire

a year ago

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis

Jim Cramer’s 10 Latest Stock Picks This Week
CABA

Insider Monkey

a year ago

Jim Cramer’s 10 Latest Stock Picks This Week

Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4
CABA

Insider Monkey

2 years ago

Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4

Cabaletta Bio to Participate in Upcoming Investor Conferences in March
CABA

GlobeNewswire

2 years ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in March

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
CABA

Business Wire

2 years ago

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
CABA

GlobeNewswire

2 years ago

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

Columbus McKinnon Corporation (NASDAQ:CMCO) Q3 2024 Earnings Call Transcript
CABA

Insider Monkey

2 years ago

Columbus McKinnon Corporation (NASDAQ:CMCO) Q3 2024 Earnings Call Transcript

Is AZZ (AZZ) Stock a Solid Choice Right Now?
CABA

Zacks

2 years ago

Is AZZ (AZZ) Stock a Solid Choice Right Now?

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
CABA

GlobeNewswire

2 years ago

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Enovix to Release Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
CABA

GlobeNewswire

2 years ago

Enovix to Release Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

Tri Counties Bank Funds CAPK’s VITA Program in Kern County for $25,000
CABA

Business Wire

2 years ago

Tri Counties Bank Funds CAPK’s VITA Program in Kern County for $25,000

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
CABA

PR Newswire

2 years ago

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

Stewart Information Services Corporation Announces Fourth Quarter 2023 Earnings Conference Call
CABA

Business Wire

2 years ago

Stewart Information Services Corporation Announces Fourth Quarter 2023 Earnings Conference Call

Gentherm (NASDAQ:THRM) Might Be Having Difficulty Using Its Capital Effectively
CABA

Simply Wall St.

2 years ago

Gentherm (NASDAQ:THRM) Might Be Having Difficulty Using Its Capital Effectively

NetScout Systems, Inc. Beat Revenue Forecasts By 10%: Here's What Analysts Are Forecasting Next
CABA

Simply Wall St.

2 years ago

NetScout Systems, Inc. Beat Revenue Forecasts By 10%: Here's What Analysts Are Forecasting Next

NovaGold Resources Inc. (AMEX:NG) Q4 2023 Earnings Call Transcript
CABA

Insider Monkey

2 years ago

NovaGold Resources Inc. (AMEX:NG) Q4 2023 Earnings Call Transcript

18 Best 52-Week Low Stocks To Buy Now
CABA

Insider Monkey

2 years ago

18 Best 52-Week Low Stocks To Buy Now

Cheaper Gas Prices Won’t Last Much Longer
CABA

Barrons.com

2 years ago

Cheaper Gas Prices Won’t Last Much Longer

Here's What Key Metrics Tell Us About Hilltop Holdings (HTH) Q4 Earnings
CABA

Zacks

2 years ago

Here's What Key Metrics Tell Us About Hilltop Holdings (HTH) Q4 Earnings

ATSG Announces New President of Airline Subsidiary ATI
CABA

Business Wire

2 years ago

ATSG Announces New President of Airline Subsidiary ATI

Barings BDC, Inc. Reports Preliminary Fourth Quarter 2023 Results
CABA

Business Wire

2 years ago

Barings BDC, Inc. Reports Preliminary Fourth Quarter 2023 Results

ZipRecruiter to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
CABA

Business Wire

2 years ago

ZipRecruiter to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

10 Best Small Cap Chemical Stocks to Buy
CABA

Insider Monkey

2 years ago

10 Best Small Cap Chemical Stocks to Buy

CABA

Business Wire

2 years ago

Hamilton Insurance Group, Ltd. to Report Fourth Quarter 2023 Financial Results on March 6, 2024

Household Products Stocks Q3 Teardown: Church & Dwight (NYSE:CHD) Vs The Rest
CABA

StockStory

2 years ago

Household Products Stocks Q3 Teardown: Church & Dwight (NYSE:CHD) Vs The Rest

Here's Why We Think Napco Security Technologies (NASDAQ:NSSC) Might Deserve Your Attention Today
CABA

Simply Wall St.

2 years ago

Here's Why We Think Napco Security Technologies (NASDAQ:NSSC) Might Deserve Your Attention Today

CRITEO TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 7, 2024
CABA

PR Newswire

2 years ago

CRITEO TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 7, 2024

An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 50% Undervalued
CABA

Simply Wall St.

2 years ago

An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 50% Undervalued

Director Jeffrey Albers Sells 10,000 Shares of Kymera Therapeutics Inc
CABA

GuruFocus.com

2 years ago

Director Jeffrey Albers Sells 10,000 Shares of Kymera Therapeutics Inc

Despite the downward trend in earnings at Stewart Information Services (NYSE:STC) the stock rallies 4.4%, bringing five-year gains to 62%
CABA

Simply Wall St.

2 years ago

Despite the downward trend in earnings at Stewart Information Services (NYSE:STC) the stock rallies 4.4%, bringing five-year gains to 62%

CABA

Associated Press Finance

2 years ago

Agilysys: Fiscal Q3 Earnings Snapshot

Hamilton Appoints Jamie Secor as Chief Underwriting Officer of US E&S Insurer Hamilton Select
CABA

Business Wire

2 years ago

Hamilton Appoints Jamie Secor as Chief Underwriting Officer of US E&S Insurer Hamilton Select

3 Shipping Stocks to Watch From a Challenging Industry
CABA

Zacks

2 years ago

3 Shipping Stocks to Watch From a Challenging Industry

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024
CABA

PR Newswire

2 years ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

Arvinas Appoints Jared Freedberg as General Counsel
CABA

GlobeNewswire

2 years ago

Arvinas Appoints Jared Freedberg as General Counsel

Equity Commonwealth Declares Series D Preferred Dividend
CABA

Business Wire

2 years ago

Equity Commonwealth Declares Series D Preferred Dividend

NAPCO Security Technologies To Present at the 26th Annual Needham Growth Conference Thursday, January 18, 2024 10:15 AM ET
CABA

PR Newswire

2 years ago

NAPCO Security Technologies To Present at the 26th Annual Needham Growth Conference Thursday, January 18, 2024 10:15 AM ET

Arhaus to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
CABA

GlobeNewswire

2 years ago

Arhaus to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

UFP Technologies (NASDAQ:UFPT) Might Have The Makings Of A Multi-Bagger
CABA

Simply Wall St.

2 years ago

UFP Technologies (NASDAQ:UFPT) Might Have The Makings Of A Multi-Bagger

Equity Commonwealth Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
CABA

Business Wire

2 years ago

Equity Commonwealth Announces Fourth Quarter and Full Year 2023 Earnings Conference Call

Is Trending Stock Energy Fuels Inc (UUUU) a Buy Now?
CABA

Zacks

2 years ago

Is Trending Stock Energy Fuels Inc (UUUU) a Buy Now?

Bull of the Day: EnerSys (ENS)
CABA

Zacks

2 years ago

Bull of the Day: EnerSys (ENS)

Should You Be Impressed By Energizer Holdings, Inc.'s (NYSE:ENR) ROE?
CABA

Simply Wall St.

2 years ago

Should You Be Impressed By Energizer Holdings, Inc.'s (NYSE:ENR) ROE?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Napco Security Technologies, Inc.'s NASDAQ:NSSC) Stock?
CABA

Simply Wall St.

2 years ago

Are Strong Financial Prospects The Force That Is Driving The Momentum In Napco Security Technologies, Inc.'s NASDAQ:NSSC) Stock?

Kymera Therapeutics Outlines Key 2024 Objectives and Strategy to Progress Leading Portfolio of Immunology and Oncology Programs
CABA

GlobeNewswire

2 years ago

Kymera Therapeutics Outlines Key 2024 Objectives and Strategy to Progress Leading Portfolio of Immunology and Oncology Programs

Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CABA

GlobeNewswire

2 years ago

Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Are Investors Undervaluing Cabaletta Bio, Inc. (NASDAQ:CABA) By 47%?
CABA

Simply Wall St.

2 years ago

Are Investors Undervaluing Cabaletta Bio, Inc. (NASDAQ:CABA) By 47%?

Share on Social Networks: